A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
- PMID: 12930925
- DOI: 10.1056/NEJMoa025142
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
Abstract
Background: For the treatment of myocardial infarction with ST-segment elevation, primary angioplasty is considered superior to fibrinolysis for patients who are admitted to hospitals with angioplasty facilities. Whether this benefit is maintained for patients who require transportation from a community hospital to a center where invasive treatment is available is uncertain.
Methods: We randomly assigned 1572 patients with acute myocardial infarction to treatment with angioplasty or accelerated treatment with intravenous alteplase; 1129 patients were enrolled at 24 referral hospitals and 443 patients at 5 invasive-treatment centers. The primary study end point was a composite of death, clinical evidence of reinfarction, or disabling stroke at 30 days.
Results: Among patients who underwent randomization at referral hospitals, the primary end point was reached in 8.5 percent of the patients in the angioplasty group, as compared with 14.2 percent of those in the fibrinolysis group (P=0.002). The results were similar among patients who were enrolled at invasive-treatment centers: 6.7 percent of the patients in the angioplasty group reached the primary end point, as compared with 12.3 percent in the fibrinolysis group (P=0.05). Among all patients, the better outcome after angioplasty was driven primarily by a reduction in the rate of reinfarction (1.6 percent in the angioplasty group vs. 6.3 percent in the fibrinolysis group, P<0.001); no significant differences were observed in the rate of death (6.6 percent vs. 7.8 percent, P=0.35) or the rate of stroke (1.1 percent vs. 2.0 percent, P=0.15). Ninety-six percent of patients were transferred from referral hospitals to an invasive-treatment center within two hours.
Conclusions: A strategy for reperfusion involving the transfer of patients to an invasive-treatment center for primary angioplasty is superior to on-site fibrinolysis, provided that the transfer takes two hours or less.
Copyright 2003 Massachusetts Medical Society
Comment in
-
Primary angioplasty for acute myocardial infarction--is it worth the wait?N Engl J Med. 2003 Aug 21;349(8):798-800. doi: 10.1056/NEJMe038116. N Engl J Med. 2003. PMID: 12930933 No abstract available.
-
Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction.N Engl J Med. 2003 Nov 27;349(22):2167-9; author reply 2167-9. doi: 10.1056/NEJM200311273492217. N Engl J Med. 2003. PMID: 14645648 No abstract available.
-
Patients with acute MI should be transferred for angioplasty.J Fam Pract. 2003 Dec;52(12):940-1. J Fam Pract. 2003. PMID: 14653979 No abstract available.
-
Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction.N Engl J Med. 2003 Nov 27;349(22):2167-9; author reply 2167-9. N Engl J Med. 2003. PMID: 14658128 No abstract available.
-
Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction.N Engl J Med. 2003 Nov 27;349(22):2167-9; author reply 2167-9. N Engl J Med. 2003. PMID: 14658129 No abstract available.
-
Angioplasty at an invasive-treatment center reduced mortality compared with first-contact thrombolysis.ACP J Club. 2004 Mar-Apr;140(2):29. ACP J Club. 2004. PMID: 15122850 No abstract available.
Similar articles
-
The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up.Eur Heart J. 2008 May;29(10):1259-66. doi: 10.1093/eurheartj/ehm392. Epub 2007 Oct 23. Eur Heart J. 2008. PMID: 17956874 Clinical Trial.
-
Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.Circulation. 2003 Dec 9;108(23):2851-6. doi: 10.1161/01.CIR.0000103122.10021.F2. Epub 2003 Nov 17. Circulation. 2003. PMID: 14623806 Clinical Trial.
-
Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.Kardiol Pol. 2006 Aug;64(8):793-9; discussion 800-1. Kardiol Pol. 2006. PMID: 16981054 Clinical Trial.
-
Timing of angiography after fibrinolysis for ST-elevation acute myocardial infarction.Curr Opin Cardiol. 2010 Jul;25(4):302-4. doi: 10.1097/HCO.0b013e328338bc92. Curr Opin Cardiol. 2010. PMID: 20308887 Review.
-
Angioplasty or fibrinolysis for acute MI? The GUSTO IIb study.Cleve Clin J Med. 1998 Feb;65(2):75-81. doi: 10.3949/ccjm.65.2.75. Cleve Clin J Med. 1998. PMID: 9509698 Review.
Cited by
-
National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention.Arch Intern Med. 2011 Nov 28;171(21):1879-86. doi: 10.1001/archinternmed.2011.481. Arch Intern Med. 2011. PMID: 22123793 Free PMC article.
-
Toward a comprehensive approach to pharmacoinvasive therapy for patients with ST segment elevation acute myocardial infarction.J Thromb Thrombolysis. 2012 Aug;34(2):180-6. doi: 10.1007/s11239-012-0722-x. J Thromb Thrombolysis. 2012. PMID: 22484515 Review.
-
ST-segment elevation myocardial infarction: Historical perspective and new horizons.Neth Heart J. 2020 Aug;28(Suppl 1):93-98. doi: 10.1007/s12471-020-01443-9. Neth Heart J. 2020. PMID: 32780338 Free PMC article. Review.
-
Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection.J Clin Pathol. 2005 Sep;58(9):1005-7. doi: 10.1136/jcp.2004.025312. J Clin Pathol. 2005. PMID: 16126892 Free PMC article.
-
Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial.Heart. 2006 Nov;92(11):1577-82. doi: 10.1136/hrt.2005.085639. Epub 2006 Jun 1. Heart. 2006. PMID: 16740918 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical